The largest bottleneck medical research organisations at the forefront of technology face is access to useful data. These difficulties stem from strict policies that limit access to ML teams instead of allowing technology to enable and ensure responsible data use. Potential ML solutions are greatly stifled due to insufficient ability to access, standardise, and aggregate valuable data that continues to be siloed away. Yet, over the last years we have seen two general paradigms emerge to address important technical challenges.

This course is promoted by Champalimaud Foundation's Fior Lab.

The scientific programme will cover

- Protocols for preparation of human cancer cells for injection;
- Generation of zebrafish xenografts (microinjection in the perivitelline space);
- Metastatic assay;
- Protocols for immunofluorescence;
- Mounting xenografts for confocal imaging;
- Confocal session.

Venue

Champalimaud Center for the Unknown, Lisbon

Dates

06 - 10 May, 2024 - 9:00

Application

Deadline: March 15

“HALLO,” Robin typed on the keyboard.
“HALLO, HOW ARE YOU FEELING?” replied ELIZA, the printed words appearing instantly on the VDU [computer screen]. 
“I’M FEELING TERRIBLE,” Robin replied. 
“WHAT DO YOU MEAN BY THAT PRECISELY?” 
“I’M FEELING DEPRESSED.” 
“WHY DO YOU THINK YOU ARE DEPRESSED?”
“BECAUSE I’M LONELY.” 
“DO YOU LIVE WITH YOUR FAMILY?”
“NO.”
“DO YOU HAVE ANY FRIENDS?” 
“NOT REALLY.” 
“WHY IS THAT?”

Imagine you’re teaching a dog to play fetch. You throw a ball, and your dog sprints after it, picks it up, and runs back. You then reward your panting pup with a treat.

These two programmes provide students with an integrative, state-of-the-art education in either Neuroscience or Cancer. A central goal of these programmes is to foster inquiry and discovery by encouraging active participation, critical thinking, and problem-solving among the students.

“Descending with his brother from the summit of Nanga Parbat, one of the ten highest mountains in the world, [Italian mountaineer] Reinhold Messner felt a third climber ‘descending with us, keeping a regular distance, a little to my right and a few steps away from me, just outside my field of vision’. Messner ‘could not see the figure’ but ‘was certain there was someone there,’ sensing ‘his presence’.

For this edition of the contest, 11 groundbreaking biomedical and health projects spearheaded by research institutions and universities in Portugal were selected. This funding underscores the commitment of the “la Caixa” Foundation to champion projects of unparalleled excellence that stand to significantly benefit public health.

Listed below is more information about the seven awardees from the four COLife institutes and their projects.

Artificial Intelligence is all around us, accelerating medical drug development, selecting what content we see across social media or outclassing us on the most human of tasks from driving to medical diagnoses. The transformational power of AI has the potential to alter our society as profoundly as the agricultural and industrial revolutions, but how did we get here?

What is intelligence, and why do we seek to replicate it artificially? 

When did the AI revolution begin, and can you recall your first encounter with AI? 

If a teacup is steaming, you’ll wait a bit longer before drinking from it. And if your fingers get caught in the door, you'll be more careful next time. These are forms of associative learning, where a positive or negative experience leads to learning behavior. We know that our cerebellum is important in this form of learning. But how exactly does this work?

On behalf of the Champalimaud Research Programme on Digital Therapeutics led by Dr. John Krakauer and Dr. Joe Paton, we'd like to invite you to the workshop on interactive AI systems. At Digital Therapeutics group, our mission is to leverage cutting-edge technology to create evidence-based, personalised medical interventions to prevent, manage, or treat a broad spectrum of physical, mental, and behavioural conditions.